Biocompatible Customized 3D Bone Scaffolds Treated with CRFP, an Osteogenic Peptide

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Orthopedic Research

Background:

• Current synthetic bone graft substitutes (BGS) face limitations in mechanical strength, stress shielding, and full integration.
• There is a need for advanced BGS that are biocompatible, mechanically robust, and promote bone regeneration.

Purpose of the Study:

• To develop and evaluate biocompatible, 3D printed scaffolds for bone regeneration.
• To assess the osteogenic potential and mechanical properties of scaffolds fabricated from acrylonitrile butadiene styrene (ABS) and Stratasys® MED 610 (MED610) materials.
• To investigate the effect of calcitonin receptor fragment peptide (CRFP) on osteogenesis and bone matrix production.

Main Methods:

• Fabrication of cylindrical scaffolds using ABS and MED610 materials via 3D printing.
• Seeding of scaffolds with MC3T3 osteoblasts and induction of osteogenesis with and without CRFP.
• Analysis of bone matrix production and mechanical compression testing (compressive strength, stiffness, elastic modulus).

Main Results:

• ABS scaffolds with CRFP treatment showed a 9.8% increase in compressive strength compared to untreated scaffolds.
• MED610 scaffolds treated with CRFP exhibited an 11.9% (polylysine pre-coating) and 20% (no pre-coating) increase in compressive strength.
• Both scaffold types demonstrated support for osteoblast growth and bone matrix production.

Conclusions:

• MED610-based 3D printed scaffolds are promising bone graft substitutes.
• CRFP augmentation significantly enhances the compressive strength and osteogenic potential of MED610 scaffolds.
• These findings suggest a new avenue for developing improved bone regeneration therapies.